Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro
Özet
Background and aim: Hepatocellular cancer (HCC) is the sixth most common cancer and liver fibrosis is strongly associated with HCC. Treatment options are limited, and preventive strategies should be developed. An important step in the beginning of liver fibrosis is a strong inflammatory response. 5-HT7 is the last recognized member of the serotonin receptor family and is expressed in both central nerve system and peripheral system and have a lot of functions like learning, memory, smooth muscular relaxation, in the control of circadian rhythms and thermoregulation, pain and migraine, schizophrenia, anxiety, cognitive disturbances, and even inflammation.
Anahtar kelimeler
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Erkayman, B., Halıcı, Z., Çadırcı, E., Karakus, E., Bayır, Y., Albayrak, A., & Unal, D. (2017). Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro. INTERNATIONAL IMMUNOPHARMACOLOGY, 43, 227–235. https://doi.org/10.1016/j.intimp.2016.12.023
BibTeX
@article{erkayman2017-19577,
author = {Erkayman, Beyzagül and Halıcı, Zekai and Çadırcı, Elif and Karakus, Emre and Bayır, Yasin and Albayrak, Abdulmecit and Unal, Deniz},
title = {Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro},
journal = {INTERNATIONAL IMMUNOPHARMACOLOGY},
year = {2017},
volume = {43},
pages = {227--235},
issn = {1567-5769},
doi = {10.1016/j.intimp.2016.12.023},
url = {https://akademik.atauni.edu.tr/yayinlar/19577-liver-5-ht7-receptors-a-novel-regulator-target-of-fibrosis-and-inflammation}
}